Alivus Life Sciences Ltd
NSE: ALIVUS BSE: 543322
₹1044.95
(-0.49%)
Wed, 06 May 2026, 04:09 pm
Market Cap128.92B
PE Ratio23.63
Dividend0.48
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2002
- The Promoter established its API business.
- A manufacturing plant was established at Kurkumbh, Maharashtra.
2003
- The first product was registered with US-FDA.
- GlaxoSmithKline's API manufacturing plant in Ankleshwar, Gujarat was acquired.
2004
- Manufacturing commenced at Mohol, Maharashtra.
2008
- The Ankleshwar plant at Gujarat was inspected by US-FDA.
2011
- The Company was incorporated as Zorg Laboratories Private Limited.
2012
- The Ankleshwar plant was inspected by PMDA and AFSSAPS.
2013
- Manufacturing commenced at Dahej, Gujarat.
- The Ankleshwar plant was inspected by COFEPRIS.
2015
- The Dahej plant was inspected by US-FDA.
2016
- The Dahej plant was inspected by PMDA Japan.
2018
- The Company was acquired by Glenmark Pharmaceuticals Limited.
- The name of the Company was changed to Glenmark Life Sciences Private Limited.
- A fresh certificate of incorporation was issued by the RoC.
- The Company was converted from a private limited company to a public limited company.
- The Dahej plant was inspected by EDQM, ANSM and US-FDA.
- The Mohol plant was inspected by US-FDA.
2019
- The API business was spun off into the Company.
- The Ankleshwar plant was inspected by US-FDA, Health Canada and PMDA Japan.
2021
- The Company achieved a milestone of 403 cumulative drug master files registrations across multiple markets globally.
2023
- The Company announced its board approved the divestment of a 75% stake in its subsidiary GLS to Nirma Ltd for Rs 5,651.5 crore.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800